LAUSR

Safer opioid prescribing patterns, naloxone distribution, and medications for opioid use disorder (M‐OUD) are an important part of decreasing opioid‐related adverse events. Veterans are more likely to experience these adverse events compared to the general population. Despite treatment guidelines and ED‐based opioid safety programs implemented throughout Veterans Affairs (VA) Medical Centers, many Veterans with OUD do not receive these harm reduction interventions. Prior research in other health care settings has identified barriers to M‐OUD initiation and naloxone distribution; however, little is known about how this may be similar or different for health care professionals in VA ED and urgent care centers.